Table of Content:
Submission to this journal occurs online. Journal of Kerman University of Medical Sciences (JKMU) only considers the manuscripts submitted in electronic form via the journal's online submission. The Editorial Office reserves the rights to return manuscripts that are not in accordance. Once you have prepared your manuscript according to the instructions below, you can then submit your work via our online submission form.
Before submitting your manuscript, please insure that you have carefully considered the following points:
For all articles
The manuscript should include:
1) title page
2) Abstract (up to 350 words subdivided into Introduction, Methods, Results, Conclusion)
3) Keywords ( minimum 3 and maximum 5 words )
4) Main text including: a) Introduction, b) Methods, c) Results, d) Discussion, e) Conclusion
5) Ethical issues
6) Author's contributions
8) Tables and/or Figures
9) Separate the title page with all authors`affiliations clearly given
11)Title should be maximum 110 characters and spaces
12) Ethics statement should be included in main body
13) On acceptance, the corresponding author will be contacted to submit an electronic copyright form
14) References should be in correct Journal style, as below:
Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding JK, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002;935(1-2):40-6.
Breedlove GK, Schorfheide AM. Adolescent pregnancy. 2nd ed.Wieczorek RR, editor.White Plains (NY): March of Dimes Education Services; 2001.
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.
For further guidance, please refer to: http://www.nlm.nih.gov/bsd/uniform_requirements.html
Articles would be in one of the following types:
Original articles: Text should be up to 8000 words; A structured abstract should be 250 words; maximum number of tables/figures should not be more than 6; maximum number of references should not be more than 40.
Case reports: Text should be up to 4000 words; An unstructured abstract should be 100 words; Maximum number tables/figures should not be more than 3; Maximum number of references should not be more than 20.
Short communication/Brief Report: Text should be up to 4000 words; An unstructured abstract should be 100 words; Maximum number tables/figures should not be more than 2; Maximum number of references should not be more than 20.
Correspondence, Letter to Editor: Text should be up to 1000 words; Maximum number of references shouldn’t be more than 15.
Review articles: Text should be up to 7000 words; A structured or unstructured abstract should be 250 words; Maximum number of tables/figures shouldn’t be more than 8; Maximum number of references shouldn’t be more than 90.
Use only standard abbreviations. Avoid using them in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement (For further information please visit ICMJE Recommendation).
A. If authors have already published a research document (eg, conference paper, working paper, discussion paper, technical report, and so on) prior to submission to the JKMU , the submitted manuscript must:
1. Have at least 30% new material/content.
2. Discuss the pre-published document and cite it in the manuscript.
3. Inform the editorial team of the pre-publication in any form at the time of submission.
4. Have a new title.
5. Have a new abstract.
6. Have a new theory or a new idea.
7. Include information in the JKMU Authorship Form and the Acknowledgements section that the manuscript is based on a pre-published document, and provide a link to the pre-published document.
B. If authors decide to publish a research document (eg, conference paper, working paper, discussion paper, technical report, and so on) while their work is under review at the JKMU, they need to address the following points:
1. Inform the JKMU editorial team of their decision and describe clearly the purpose of pre-publication.
2. Provide the link of the pre-publication server (where they want to publish the research document) to the JKMU office.
3. Provide the draft of research document to the JKMU office.
4. Make sure the content of research document is at least 30% different from the manuscript under review at the JKMU .
5. Cite the research document in the JKMU article at the later stages of the peer-review process if the manuscript is not rejected.
Please visit our full ethics guidelines on the Publication Ethics page.
All JKMU publications are in English. Authors whose first language is not English should make sure their manuscript is written in idiomatic English before submission. Please write your text in good English (American or British usage is accepted, but not a mixture of these). No language and copy-editing services are provided by the JKMU. Hence, authors who feel their manuscript may require editing to eliminate possible grammatical or spelling errors are encouraged to obtain such services prior to submission. Authors are responsible for all costs associated with such services.
By submitting an article, you ensure that your work has not been published previously, except in the form of a conference abstract or as part of a published lecture or thesis for an academic qualification (please see the Pre-publication Guidelines). This implies that the manuscript is not under consideration for publication elsewhere and its submission is approved by all authors and responsible authorities where the work was carried out. It is highly important that if an acceptance is offered, your work will not be published elsewhere in the same form, in English or in any other languages, including electronically without the written consent of the Kerman University of Medical Sciences as the Publisher. Authors should not submit the same manuscript, in the same or different languages, simultaneously to more than one journal (For further information please visit ICMJE Recommendation).
Submission to this journal occurs online. Manuscripts submitted via email are not processed. Please read the following instructions carefully and follow them closely to ensure that the review and publication of your article is as efficient and quick as possible. International Journal of Health Policy and Management only considers the materials submitted in electronic form via the journal's online submission system. The editorial office reserves the rights to return manuscripts that are not in accordance with the JKMU instructions for authors. Once you have prepared your manuscript according to the instructions below, you can then submit your work via our online submission platform.
During the online submission process, authors are asked to provide:
1) Manuscript Type:
2) Manuscript Title: authors need to insert the main and running title
3) Journal section: It includes Health Policy, Health Management, Global Health, Politics of Health, Health Policy Ethics, Health Economics, and Epidemiology
6) Related Subjects: authors need to insert the related subject
7) Additional Comments: authors can mention any concern or issue that editorial office need to know in this section
8) Suggested Reviewers: authors can provide the names and email addresses of potential reviewers. Please note that the editors retain the right to decide whether or not the suggested reviewers are invited
9) Attach Files: authors MUST upload the following four mandatory files and forms:
a) Title Page:
b) Main Manuscript:
c) Authorship Form:
d) Conflict of Interest Disclosure Form:
Note: uploading the supplementary files (eg, excel sheets) are optional. 10) Cover Letter & Checklist: uploading cover letter is optional
11) Finish Submission: authors need to review the submission before clicking the submit button.
All manuscripts submitted to the JKMU are checked by the editorial office for conformance to the JKMU instructions. Non-conforming manuscripts are returned to authors.
The title page should include:
1. Manuscript Type:
2. Manuscript Title:
3. Authors’ Information: please add the authors’ information according to the Authorship Form.
5. Source(s) of Support: Authors are requested to clearly identify sources who provided financial support for the conduct of research and/or preparation of the manuscript. Authors have to briefly describe the role of the funder/sponsor in any part of the work including design and conduct of the study, data collection, data management, data analysis and interpretation, preparation, review and approval of the manuscript. The following rules should be followed:
- The sentence should begin with: ‘This work was supported by …’.
- The full official funding agency name should be given, i.e. ‘the National Cancer Institute at the National Institutes of Health’ or simply 'National Institutes of Health' not ‘NCI'(one of the 27 sub-institutions) or 'NCI at NIH’.
- Grant numbers should be complete and accurate and provided in brackets as follows: ‘[grant number ABX CDXXXXXX]’
- Multiple grant numbers should be separated by a comma as follows: ‘[grant numbers ABX CDXXXXXX, EFX GHXXXXXX]’
- Agencies should be separated by a semi-colon (plus ‘and’ before the last funding agency)
6. Word Count
7. Disclosure of Relationships and Activities: This form must be completed by the corresponding author only. Please paste the generated disclosure statement on the Title Page.
8. Ethical Issues: Please identify the ethics committee/board that has approved the research. If the manuscript is Original Article or Short Communication this field should be filled.
10. Authors’ Contributions
Please find more information about each section by visiting the ICMJE recommendations.
Important Note: While submitting your manuscript please bear in mind to upload the Authorship From. This form must be completed by the corresponding author and signed digitally by all authors. Please find the instructions below:
All contributing authors should qualify for authorship. The order of authorship should be a joint decision of the co-authors. Sufficient participation in the work is of utmost importance. Authorship credit should be based on substantial contribution to conception and design, execution, or analysis and interpretation of data. All authors should be involved in drafting the manuscript or revising it critically for important intellectual content, must have read and approved the final version of the manuscript and approve of its submission to the JKMU . Any change in authorship following initial submission would have to be agreed by all authors as would any change in the order of authors (For further information please visit ICMJE).
Important Note: The Authorship Form should be signed digitally by ALL AUTHORS.
This statement concerns the addition, deletion, or rearrangement of author names in the authorship of submitted manuscripts as described below:
During the peer-review process if any change/s in the authorship is requited, the corresponding author should send a request to add or remove an author, or to rearrange the author names of the submitted manuscript. The corresponding author must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) a signed JKMU Change to Authorship Form by all authors that they agree with the addition, removal or rearrangement. Requests that are not sent by the corresponding author will be forwarded by the Journal Managing Editor to the corresponding author, who must follow the procedure as described above. No authorship change is allowed after acceptance and publication of the manuscript.
Authors are allowed to designate maximum two first authors or two corresponding authors. In such cases, the lead corresponding author has to justify the reason. Please find more details below:
If two first authors have equal contribution, authors can be indicated the joint first authors by using ¶ symbol with the caption ‘Both authors contributed equally to this paper’ immediately under the address list in the Title Page. More than two first authors are not allowed. Authors have to decide on the order of the two first authors (e.g. alphabetically).
If two co-authors have equal contribution, authors can be indicated the co-corresponding authors by using * symbol with the caption ‘Both authors contributed equally to this paper’ immediately under the address list in the Title Page and provide the email and full address of both. More than two corresponding authors are not allowed. Only one of the corresponding authors, who is designated at the time of submission as the lead corresponding author, should accept the contact responsibility. The Disclosure Form should be completed by the lead corresponding author.
Acceptable manuscripts' file formats include Microsoft Word and WordPerfect. Please do not submit your manuscripts in PDF format.
Use A4 size. Text should be left-justified. Use 12-point font size. Use preferably Times and New Romans font. Use 1.5 line spacing. Use line and page number. Use Initial Upper Case for Title, Headings and Subheadings, Keywords. Make the titles, headings and subheadings bold or use different colour. Use footnote at the end of manuscript before references (no footnote for each page). Make the files anonymous; please find the guide for Office below:
Open your word file-- Clink on “File” button—“Check for Issues” section-- Select “Inspect Document”-- Click on “Inspect” button-- Click “Remove All” next to Document Properties and Personal Information-- Finally save the changes.
Main Manuscript Sections
The manuscript should follow through these sections: Abstract, Key Messages (only for Original Articles), Keywords, Background, Methods, Results, Discussion, Conclusion, and References. However, it may be appropriate to combine the discussion and conclusion sections in some articles. Tables and Figures should be inserted within the text as close as possible to where they are referenced. Authors should not upload them as separate files. Please add page numbers and line numbers for your manuscript.
Include a structured abstract of no more than 300 words for original articles and reviews. The abstract should state briefly and clearly the purpose and setting of the research, the principal findings and major conclusions, and the article's contribution to knowledge. Abstracts should be prepared in JKMU style including background, methods, results, and conclusion. For other manuscript types , include an unstructured abstract of no more than 250 words that summarizes the objectives and background, main points and conclusions of the article. Abstracts are not required for correspondence and letters to editor.
In line with the knowledge translation activities of the JKMU , authors of original articles MUST include the following two sections after abstract:
1. Implications for policy makers
For this section, authors should provide a minimum of 3 and maximum 5 bullet-points as practical recommendations for policy makers; i.e. how policy makers could benefit from the results of their research.
2. Implications for public
For this section, authors should write a short summary/story, 100-150 words, and let the public know how your research results could possibly benefit them.
Authors need to add up to 6 keywords separately into the online system during submission, and should accurately reflect the content of the article. Abbreviations/acronyms could be used with their expansions. The keywords will be used for indexing purposes.
Please prepare the keywords according to the following instructions:
NOTE: JKMU follows AMA style (American Medical Association Manual of Style, 10th Edition) since May 2015.
-Items are listed numerically in the order they are cited in the text.
-Include up to 6 authors.
-For more than 6, provide the names of the first 3 authors and then add et al.
-If there is no author, start with the title.
- Journal article (1-6 authors)
Michaud J, Kates J. Global health diplomacy: Advancing foreign policy and global health interests. Glob Health Sci Pract. 2013;1(1):24-28. doi:10.9745/GHSP-D-12-00048
- Journal article (more than 6 authors)
Hu WS, Ting WJ, Chiang WD, et al. The heart protection effect of alcalase potato protein hydrolysate is through IGF1R-PI3K-Akt compensatory reactivation in aging rats on high fat diets. Int J Mol Sci. 2015;16(5):10158-10172. doi: 10.3390/ijms160510158
- Journal article (non-English title)
1- If non-English language titles are translated into English, bracketed indication of the original language should follow the title:
Richartz E, Schott KJ, Wormstall H. Psychopharmakotherapie bei Demenzerkrankungen [in Japanese]. Dtsch Med Wochenschr. 2004;129(25/26):1434-1440.
2- If both the non-English language title and the translation are provided, both may be given with the non-English title given first, followed by the English Translation in brackets:
Camici M. Cancro prostatico e screening con test PSA [Prostate cancer and prostate specific antigen screening]. Minerva Med. 2004;95(1):25-34.
Reuter T. Sharing the Earth, Dividing the Land: Land and Territory in the Austronesian World. Canberra: Australian National University Press; 2006.
- Book Section
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, eds. The Genetic Basis of Human Cancer. New York: McGraw-Hill; 2002:93-113.
- Newspaper article – in print
Wolf W. State’s mail-order drug plan launched. Minneapolis Star Tribune. May 14, 2004:1B.
- Newspaper article – online
Pollack A. FDA approves new cystic fibrosis drug. New York Times. January 31, 2012. https://www.nytimes.com/2012/02/01/business/fda-approves-cystic-fibrosis-drug.html?ref=health. Accessed February 1, 2012.
Outbreak notice: Cholera in Haiti. Centers for Disease Control and Prevention website. https://wwwnc.cdc.gov/travel/notices/outbreak-notice/haiti-cholera.htm. Updated January 9, 2012. Accessed February 1, 2012.
Weisbaum LD. Human sexuality of children and adolescents: a comprehensive training guide for social work professionals [thesis]. Long Beach (CA): California State University; 2005.
Chu H, Rosenthal M. Search engines for the World Wide Web: a comparative study and evaluation methodology. Paper presented at: American Society for Information Science 1996 Annual Conference; October 19 24, 1996; Baltimore, MD. https://www.asis.org/annual-96/electronicproceedings/chu.html. Accessed February 26, 200
For the reporting of statistical analyses please consider the following points:
1. Use only standard abbreviations such as AIDS, HIV, WHO, IQ.
2. Do not use non-standard abbreviations unless they appear at least 3 times in the text.
3. Avoid abbreviations in the title of the manuscript.
4. The spelled-out abbreviation followed by the abbreviation in parenthesis should be used upon first appearance in the text unless the abbreviation is a standard unit of measurement (For further information please visit ICMJE Recommendation).
5. Keep abbreviations to a minimum.
Authors should provide the Supplementary Information (SI) as supplementary files once they submit the main manuscript. Authors are not allowed to change the content of supplementary files following acceptance. The supplementary files will be published exactly as they are received from the authors without any editing or reformatting. JKMU does not take responsibility for any information provided in the supplementary files. We accept no more than 5 files (each file maximum 10 pages). Please prepare the supplementary files based on the following instructions:
Each supplementary file should include:
1. Article title
2. Journal name
3. Authors information including author names, affiliation, and email address of the corresponding author.
4. Main content such as tables, figures, description method.
5. We suggest not adding references to the supplementary files since we do not activate the links and they are not counted as citation. However, if you need to insert the references within the supplementary file, they should be cited in order following the references in the main text as per JKMU style.
6. Please insert page number for all supplementary files.
1. Please use separate numbering system for tables and figures eg, Table S1, Table S2.
2. Please cite all supplementary files’ material in the main manuscript based on the numbering order.
Please provide a concise, descriptive caption for each supplementary material eg, Tables and Figures.
1. Please choose an appropriate title (precise and concise) for each supplementary file eg, Supplementary File 1. Search Strategy.
2. We accept .pdf, .doc, .xls and .ppt formats.
Please decrease the files’ size as small as possible so that they can be downloaded easily.
The corresponding author should submit the revisions via the JKMU portal according to the following instruction:
Please go to your profile (Author section)--"Submissions Needing Revision" section--Click on your manuscript ID--Upload the correct version and delete any old versions (you can change all information eg, title, abstract, etc.)--and push the "submit" button.
Please Do NOT start a New Submission and Do NOT send the revisions via email.
Corresponding author will be sent page proofs (as PDF files) by email. These should be checked immediately and corrections, as well as answers to any queries, returned to the journal as an annotated PDF via email within 3-5 working days (further details are supplied with the proof). It is the author's responsibility to check proofs thoroughly. You will need to download Adobe Reader version 11 available free from Adobe or Foxit Reader.
We will do everything possible to get your article published quickly and accurately. Therefore, it is important to ensure that all of your corrections are sent back to us in one communication. Please note that rephrasing sentences, additions, or omissions are not allowed at the proof stage.
Important Note: Authors should approve the PDF proof and provide us with the corrections in due time. Not meeting the deadline and a long delay to respond could lead to withdraw of the manuscript at this stage. Please note that NO further edits/corrections are accepted after publication. Authors MUST check the PDF proof very carefully.
Ethical Issues is obligatory section in all types of articles. If there is no ethical issue to be considered, please declare it as “not applicable” or “None to be declared”. Every experimental or clinical study may raise controversial ethical issues (e.g., Institutional Ethical Approval for working with animal or human subjects). Thus, JKMU expects all authors, reviewers and editors to consider COPE (Committee on Publication Ethics), ICMJE and Equator Network’s reporting guidelines in medical ethics plus scientific writing. If any, authors should state related declaration(s), unless otherwise the following sentence should be given “None to be declared”.
Ethical considerations must be addressed in the main body.
1) Please state that informed consent was obtained from all human adult participants and from the parents or legal guardians of minors. Include the name of the appropriate institutional review board that approved the project.
2) Indicate in the text that the maintenance and care of experimental animals complies with National Institutes of Health guidelines for the humane use of laboratory animals, or those of your Institute or agency.
Please take a look at the following guidelines provided by COPE for editors and reviewers that may be helpful for authors, too:
In case of any financial support, it is important to mention the name of the respective organization/institute and the project number at the end of the manuscript.
Authors must acknowledge and declare any sources of funding and potential conflicting interest, such as receiving funds or fees by, or holding stocks and shares in an organization that may profit or lose through publication of your paper. Declaring a competing interest will not lead to automatic rejection of the paper, but we would like to be made aware of it.
There are no charges for publication in this Journal.
Open Access agreement
Upon submitting an article, authors are asked to indicate their agreement to abide by an Open Access Creative Commons license. Under the terms of this license (http://creativecommons.org/licenses/by/4.0/), authors retain ownership of the copyright of their articles. However, the license permits any user to download, print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work. The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive..
All manuscripts are considered to be confidential. They are blind peer reviewed by at least 2 anonymous reviewers selected by the Editorial Board. The corresponding author is notified as soon as possible of the editor decision to accept, reject, or require modifications.
JKMU is committed to publish the original studies and timely reviews that have neither been published nor is under review elsewhere. JKMU is powered by CrossCheck™, iThenticate™ and all the submitted manuscripts are subjected to the CrossCheck. Taken all, all plagiarized materials will incur the “Plagiarism Sanctions”. Submitted manuscripts, which are found to be published or under review elsewhere, will be sustained and experience the “Duplicated Publication Sanctions”. Submitted Manuscripts, which are found to include either fabricated or falsified data including the manipulation of images, will confront with the “Data Fabrication/Falsification Sanctions”.
The JKMU will follow the COPE guidelines to deal with cases of potential publication misconduct.
Based on the COPE guidelines, JKMU will consider retracting a publication if:
In the case of occurrence documented violations of the aforementioned policies of JKMU’s, it is the JKMU’s right to apply the following sanctions:
Pleases download the additional resources for further consideration. These include: